Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses
Open Access
- 27 September 2025
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 243, 106284
Abstract
No abstract availableKeywords
Funding Information
- Health Canada
- Government of Canada
This publication has 82 references indexed in Scilit:
- Molecular and ecological determinants of mammalian adaptability in avian influenza virusInfection, 2025
- Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A VirusJournal of Medical Virology, 2025
- High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature ReviewAdvances in Therapy, 2023
- Multifunctional cytokine production reveals functional superiority of memory CD4 T cellsEuropean Journal of Immunology, 2019
- Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutininAntiviral Research, 2013
- Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza VaccineJournal of Clinical Immunology, 2012
- Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypesImmunogenetics, 2011
- Optimizing peptide matrices for identifying T‐cell antigensCytometry Part A, 2008
- Conserved Determinants for CD4+ T Cells within the Light Chain of the H3 Hemagglutinin Molecule of Influenza VirusVirology, 1994
- Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A virusesVirology, 1991